← GSK plc GSK
Market Price
$49.54
Market Cap
$101.06B
P/E Ratio
N/A
Revenue (FY 2025)
↑4.1% YoY
$32.67B
3-Yr CAGR: 3.7%
Net Income
↑52.4% YoY
$573.00M
Net Margin: 1.8%
Free Cash Flow
↓-351.9% YoY
-$122.00M
FCF Yield: -0.12%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: 0.9%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (GSK)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $27,889.0M | — | $18,599.0M | $150.0M | — | — | — | $1,609.0M | — | — |
| FY 2017 | $30,186.0M | +8.2% | $19,844.0M | $637.0M | +324.7% | — | — | $1,340.0M | $-205.0M | — |
| FY 2018 | $30,821.0M | +2.1% | $20,580.0M | $423.0M | -33.6% | — | — | $1,326.0M | $-18.0M | +91.2% |
| FY 2019 | $33,754.0M | +9.5% | $21,891.0M | $623.0M | +47.3% | — | — | $1,512.0M | $247.0M | +1,472.2% |
| FY 2020 | $34,099.0M | +1.0% | $22,395.0M | $639.0M | +2.6% | — | — | $1,655.0M | $429.0M | +73.7% |
| FY 2021 | $34,114.0M | +0.0% | $22,511.0M | $711.0M | +11.3% | — | — | $1,291.0M | $119.0M | -72.3% |
| FY 2022 | $29,324.0M | -14.0% | $19,770.0M | $665.0M | -6.5% | — | — | $-1,310.0M | $-2,307.0M | -2,038.7% |
| FY 2023 | $30,328.0M | +3.4% | $21,763.0M | $380.0M | -42.9% | — | — | $-1,328.0M | $-2,614.0M | -13.3% |
| FY 2024 | $31,376.0M | +3.5% | $22,328.0M | $376.0M | -1.1% | — | — | $1,307.0M | $-27.0M | +99.0% |
| FY 2025 | $32,667.0M | +4.1% | $23,650.0M | $573.0M | +52.4% | — | — | $1,202.0M | $-122.0M | -351.9% |
Valuation
Market Price
$49.54
Market Cap
$101.06B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
N/A
FCF Yield
-0.12%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
72.40%
Operating Margin
24.28%
Net Margin
1.75%
Return on Equity (ROE)
N/A
Return on Assets (ROA)
0.94%
Asset Turnover
0.53x
Revenue 3-Yr CAGR
3.66%
Financial Health & Liquidity
Current Ratio
N/A
Cash Ratio
N/A
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
N/A
Total Debt
N/A
Book Value / Share
N/A
Cash Flow Efficiency
Operating Cash Flow
$1.20B
Capital Expenditures (CapEx)
$1.32B
Free Cash Flow
-$122.00M
OCF / Revenue
3.68%
FCF / Revenue
-0.37%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
N/A
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$61.12B
Total Liabilities
$45.16B
Stockholders' Equity
N/A
Current Assets
N/A
Current Liabilities
N/A